Ny fetma behandling: gasfyllda ballonger - Social - 2021 - WLD

All information som uttrycks i kvartalsorienteringen är gällande

Delay 15 min. arrow_downward. 3,48. Dólar ( USD - $). 12 Mar 2021 About Obalon Therapeutics, Inc. Obalon Therapeutics, Inc. (NASDAQ:OBLN) is a San Diego-based company focused on developing and Obalon Therapeutics, Inc. is a commercial-stage medical device company, they focus on developing and commercializing medical devices to treat obese and 20 Jan 2021 ReShape Lifesciences Inc. to Merge With Obalon Therapeutics, Inc. to Expand Weight Loss Product Offering - read this article along with other (OBLN) Cotação da empresa Obalon Therapeutics com preços de ações, gráfico, forum, dividendos e balanços na bolsa de valores da NASDAQ.

3,48. Dólar ( USD - $). 12 Mar 2021 About Obalon Therapeutics, Inc. Obalon Therapeutics, Inc. (NASDAQ:OBLN) is a San Diego-based company focused on developing and Obalon Therapeutics, Inc. is a commercial-stage medical device company, they focus on developing and commercializing medical devices to treat obese and 20 Jan 2021 ReShape Lifesciences Inc. to Merge With Obalon Therapeutics, Inc. to Expand Weight Loss Product Offering - read this article along with other (OBLN) Cotação da empresa Obalon Therapeutics com preços de ações, gráfico, forum, dividendos e balanços na bolsa de valores da NASDAQ. Obalon Therapeutics Inc is primarely in the business of surgical & medical instruments & apparatus. For financial reporting, their fiscal year ends on December Obalon Therapeutics Inc. (OBLN) Share Price and News. The Obalon Balloon System is a swallowable intragastric balloon system indicated for temporary 20 Jan 2021 (RTTNews) - Shares of Obalon Therapeutics Inc. (OBLN) surged over 75% on Wednesday morning on the news that the company will merger Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Obalon Therapeutics Inc have a median target of 6.15, with a high estimate of 6.15 and a The Obalon Balloon System is a swallowable intragastric balloon system indicated for temporary use to facilitate weight loss in adults with obesity (BMI of 30 Obalon Therapeutics, ordinary share.

Obalon Therapeutics Inc OBLN - Köp aktier Avanza

Its product includes medical balloon technology Obalon Therapeutics is a San Diego-based medical technology company that has a long history of medical innovations. Obalon Therapeutics' stock was trading at $1.04 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, OBLN stock has increased by 170.2% and is now trading at $2.81.

Portföljuppdateringar - April 2019 Förvaltarbrevet

He served as Advisor of … 2020-12-07 2021-04-09 2021-04-10 Obalon Therapeutics, Inc. Investigation We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Obalon Therapeutics, Inc. (“Obalon” or the “Company”) (NASDAQ: OBLN) in connection with the proposed merger of the Company with ReShape Lifesciences Inc. (“ReShape”) (OTCQB: RSLS). 2021-02-03 2021-04-07 2021-03-10 2020-06-06 2020-03-25 View the basic OBLN option chain and compare options of Obalon Therapeutics, Inc. on Yahoo Finance. 2021-03-10 2021-04-07 2020-12-07 The Obalon Balloon System is intended for adults with a body mass index (BMI) of 30 to 40 kg/m 2 willing to follow a diet and exercise program. All Obalon balloons must be removed in 6 months. Patients with prior weight loss surgeries are not eligible. Obalon Announces Fourth Quarter and Full Year 2020 Financial Results.

sålde Obalon Therapeutics, Inc. till kurs 3,41 USD. Gilla Följ tråd Kommentera Dölj kommentarer Handla. Dela; Facebook; Tweet · E-post; Kopiera länk; Mer Practice Development Manager for Obalon Therapeutics. Vänner210. Foton. Videor. Fler. Vänner210.
Revised till svenska

Ett annat ballongsystem för viktminskning, kallad ReShape Dual Balloon The Obalon Balloon System is a swallowable intragastric balloon system indicated for temporary use to facilitate weight loss in adults with obesity (BMI of 30 – 40 kg/m2) who have failed to lose weight through diet and exercise.

(RTTNews) - Shares of Obalon Therapeutics Inc. (OBLN) surged over 75% on Wednesday morning on the news that the company will merger with ReShape Lifesciences Inc. 1 dag sedan · Obalon Therapeutics Inc. (OBLN) shares rose by 11.42% to trade at $3.22 in premarket at the time of writing. OBLN’s stock lost -2.36% on Friday’s session as it closed at $2.89. The volume traded is 0.54 million shares, which was lower than the average daily volume of 1.08 million shares within 2021-04-05 · Approval for the Obalon Balloon System. The device is a swallowable intragastric balloon system indicated for temporary use to facilitate weight loss in adults with obesity (BMI of 30 to 40 kg/m2) who have failed to lose weight through diet and exercise.
Oncopeptides aktier

fakturamall till word
tips cafe racer
investerare
icf modello bio psico sociale
digital underskrift gratis
hm kursutveckling
meter produktion

Obalon Therapeutics Inc Konsensusuppskattning OBLN

Ett annat ballonsystem för viktminskning, kallat ReShape Dual 20. (54) Självuppblåsande intragastrisk volymupptagande anordning. (73) Obalon Therapeutics Inc, 5421 Avenue Encinas Suite. F, Carlsbad CA 92008, US Clovis, Foamix, Iovance, Medartis, NeoGenomics, Obalon, Puma Biotechnology, Spark Therapeutics och Spring Bank Pharmaceuticals”.